Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740192 · ClinicalTrials.gov registry record · Early Phase 1
Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?
A Early Phase 1 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 128
- Enrollment target
NCT02740192: Completed Early Phase 1 study, sponsored by Henry Ford Health System.
NCT02740192 is a Early Phase 1 study that has completed, run by Henry Ford Health System. The registered enrollment target is 128 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (142% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02740192, a Early Phase 1 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 128 participants
- Enrollment target
Study Summary
This is a randomized, double blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring total knee arthroplasty will be eligible. The study compares pain control, opioid consumption, and physical exam findings in patients undergoing total knee arthroplasty between patients receiving adductor canal block and those who receiving periarticular injection alone.
Primary Outcome
Patients' pain levels will be recorded every 6 hours using VAS (Visual Analog Scale) by the nursing staff from when the patient arrives on the inpatient floor to when the patient is discharged from the hospital.
Interventions
- DRUG Bupivacaine
- DRUG Ropivacaine
- PROCEDURE Adductor Canal Block
- PROCEDURE Periarticular Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-12 |
| Phase | Early Phase 1 |
What the finished NCT02740192 record still lists
NCT02740192 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (142% higher).
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT02740192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02740192 about?
NCT02740192 is a clinical study titled "Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?". This is a randomized, double blinded, standard of care controlled clinical trial. All adult patients over eighteen desiring total knee arthroplasty will be eligible. The study compares pain control, opioid consumption, and physical exam findings in patients undergoing total knee arthroplasty between...
What is the current status of trial NCT02740192?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 128 participants. The study started on 2016-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02740192?
The interventions under investigation include: Bupivacaine (DRUG), Ropivacaine (DRUG), Adductor Canal Block (PROCEDURE), Periarticular Injection (PROCEDURE).
Who is sponsoring clinical trial NCT02740192?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02740192's enrollment target sits among peer trials
128 139th of 2000 higher than 1,862 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia